The GLP-1 tirzepatide is only one half of the puzzle.
Changes in purchasing patterns after glucagon-like peptide-1 receptor agonist (GLP-1RA) initiation were seen across most nutrient ...
Key market opportunities for GLP-1 analogues include growth in the oral administration segment, expanding presence in Asia-Pacific and emerging markets, and strategic partnerships. Regulatory ...
Grocery industry organisation IGD (the Institute of Grocery Distribution) has launched an insight programme focused on GLP-1 ...
US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...
Drugs like Ozempic already have a big impact on how much patients eat - and now they may be changing the way they shop and ...
This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in ...